Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
27612 | 184 | 34.6 | 50% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
288 | 18308 | SEROTONIN//5 HT1A RECEPTOR//5 HT1A RECEPTORS |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | NEUROBEHAV NEUROBIOL NEUROPSYCHOL UNIT | Address | 3 | 100% | 2% | 3 |
2 | TANDOSPIRONE CITRATE | Author keyword | 1 | 100% | 1% | 2 |
3 | 3 MT | Author keyword | 1 | 50% | 1% | 1 |
4 | 5 HYDROXYTRYPTAMINE RECEPTOR SUBTYPES | Author keyword | 1 | 50% | 1% | 1 |
5 | ALEXIS CARREL | Address | 1 | 50% | 1% | 1 |
6 | BRAIN DIS NEUROL | Address | 1 | 50% | 1% | 1 |
7 | BUSIPRONE | Author keyword | 1 | 50% | 1% | 1 |
8 | CEREBELLAR GRANULE CELL GC | Author keyword | 1 | 50% | 1% | 1 |
9 | DEGENERATIVE ATAXIA | Author keyword | 1 | 50% | 1% | 1 |
10 | DENTATORUBRO PALLIDOLUYSIAN ATROPHY | Author keyword | 1 | 50% | 1% | 1 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | BLIND DRUG PLACEBO | 24 | 91% | 5% | 10 |
2 | LEVOROTATORY FORM | 15 | 63% | 8% | 15 |
3 | ELICITED INHIBITION | 3 | 60% | 2% | 3 |
4 | HYDROXYTRYPTOPHAN | 3 | 60% | 2% | 3 |
5 | CEREBELLAR ATAXIC MICE | 2 | 67% | 1% | 2 |
6 | BIOCHEMICAL SURVEY | 1 | 100% | 1% | 2 |
7 | DEGENERATIVE ATAXIAS | 1 | 50% | 1% | 2 |
8 | INHERITED OLIVOPONTOCEREBELLAR ATROPHY | 1 | 16% | 3% | 6 |
9 | H 3 CITALOPRAM BINDING | 1 | 27% | 2% | 3 |
10 | VENTRAL MESENCEPHALIC TEGMENTUM | 1 | 17% | 2% | 4 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Treatment of cerebellar ataxia with 5-HT1A agonist | 2005 | 11 | 27 | 44% |
Serotonergic neuromodulation in the cerebellar cortex: Cellular, synaptic, and molecular basis | 2001 | 29 | 79 | 38% |
Cerebellar aminergic neuromodulation: towards a functional understanding | 2004 | 61 | 109 | 17% |
An update on neurochemistry and pharmacological therapy of the cerebellar ataxias | 2007 | 9 | 97 | 31% |
Effects of tandospirone on "5-HT1A receptor-associated symptoms" in patients with Machado-Josephe disease - An open-label study | 2004 | 12 | 15 | 40% |
Effectiveness and Safety of Treatments for Degenerative Ataxias: A Systematic Review | 2009 | 22 | 42 | 26% |
The physiological effects of serotonin on spontaneous and amino acid-induced activation of cerebellar nuclear cells: An in vivo study in the cat | 1997 | 11 | 36 | 36% |
Buspirone, a serotonergic 5-HT1A agonist, is active in cerebellar ataxia. A new fact in favor of the serotonergic theory of ataxia | 1997 | 12 | 30 | 33% |
THEORETICAL BASIS AND PROPOSALS FOR A NEUROPHARMACOLOGICAL APPROACH TO CEREBELLUM ATAXIA | 1993 | 3 | 42 | 48% |
RECENT ADVANCES IN THE TREATMENT OF CEREBELLAR ATAXIAS | 1986 | 10 | 17 | 65% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | NEUROBEHAV NEUROBIOL NEUROPSYCHOL UNIT | 3 | 100% | 1.6% | 3 |
2 | ALEXIS CARREL | 1 | 50% | 0.5% | 1 |
3 | BRAIN DIS NEUROL | 1 | 50% | 0.5% | 1 |
4 | FOR UNGSGESELL AFT KOGNIT NEUROL | 1 | 50% | 0.5% | 1 |
5 | MED RECH SCI NEUROL PHYSIOL | 1 | 50% | 0.5% | 1 |
6 | NEW JERSEY MED ANAT CELL BIOL | 1 | 50% | 0.5% | 1 |
7 | RECH ATAXIE | 1 | 50% | 0.5% | 1 |
8 | UNIT NEUROL COMPORTEMENT NEUROBIOL NEUROPSYCHOL | 1 | 50% | 0.5% | 1 |
9 | CANARY ISL HLTH FDN | 0 | 33% | 0.5% | 1 |
10 | HOSP UNIV PROFESSOR EDGAR SANTOS | 0 | 33% | 0.5% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000184882 | FRIEDREICH ATAXIA//FRIEDREICHS ATAXIA//FRATAXIN |
2 | 0.0000165562 | SHIBATA S NAT MED MAT//CELL SYN T PHYSIOL//NEURONAL ENSEMBLE ACTIVITY |
3 | 0.0000160240 | NEURONTOGENY//DEV NEUROCHEM//PET 1 |
4 | 0.0000148143 | ZEBRIN II//PURKINJE CELL//ZEBRIN |
5 | 0.0000125921 | MACHADO JOSEPH DISEASE//SPINOCEREBELLAR ATAXIA//SCA2 |
6 | 0.0000115047 | INFERIOR OLIVE//COMPLEX SPIKE//CLIMBING FIBERS |
7 | 0.0000104021 | DORSAL RAPHE NUCLEUS//NUCLEUS CENTRALIS SUPERIOR//MEDIAN RAPHE NUCLEUS |
8 | 0.0000086536 | L THREO 3 4 DIHYDROXYPHENYLSERINE//3 4 DIHYDROXYPHENYLSERINE//AMINE PRECURSOR THERAPY |
9 | 0.0000082536 | MULTIPLE SYSTEM ATROPHY//STRIATONIGRAL DEGENERATION//OLIVOPONTOCEREBELLAR ATROPHY |
10 | 0.0000081011 | BAY X 3702//UMR 7521LN2C//SEROTONIN MODULATED ANTICONSOLIDATION PROTEIN |